Transfusion requirements in patients with COVID-19

Amy P Worrall¹, Claire Kelly², Aine O'Neill¹, Niamh Reidy¹, Murray O'Doherty¹, Lisa Griffin², John Quinn^{2

3}, Patrick Thornton^{2

3}, Fidelma Fitzpatrick^{4

5}, Ger F Curley⁶, Ross Morgan⁷, Siobhan Glavey^{2

8}, Cora McNally^{1

9}, Samuel McConkey^{1

9}, Philip Murphy², Eoghan de Barra^{1

9}, Michelle Lavin^{2

10}

Affiliations

¹ Department of Infectious Diseases, Beaumont Hospital, Dublin, Ireland.
² Department of Haematology, Beaumont Hospital, Dublin, Ireland.
³ School of Medicine, RCSI, Dublin, Ireland.
⁴ Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
⁵ Department of Clinical Microbiology, RCSI, Dublin, Ireland.
⁶ Department of Anaesthesia and Critical Care, RCSI, Dublin, Ireland.
⁷ Department of Respiratory Medicine, Beaumont Hospital/RCSI, Dublin, Ireland.
⁸ Department of Molecular Medicine, RCSI, Dublin, Ireland.
⁹ Department of International Health and Tropical Medicine, RCSI, Dublin, Ireland.
¹⁰ Irish Centre for Vascular Research, School of Pharmacy & Biomedical Sciences, RCSI, Dublin, Ireland.

Amy P Worrall et al. Eur J Haematol. 2021 Jan.

. 2021 Jan;106(1):132-134.

doi: 10.1111/ejh.13521. Epub 2020 Oct 9.

¹ Department of Infectious Diseases, Beaumont Hospital, Dublin, Ireland.
² Department of Haematology, Beaumont Hospital, Dublin, Ireland.
³ School of Medicine, RCSI, Dublin, Ireland.
⁴ Department of Microbiology, Beaumont Hospital, Dublin, Ireland.
⁵ Department of Clinical Microbiology, RCSI, Dublin, Ireland.
⁶ Department of Anaesthesia and Critical Care, RCSI, Dublin, Ireland.
⁷ Department of Respiratory Medicine, Beaumont Hospital/RCSI, Dublin, Ireland.
⁸ Department of Molecular Medicine, RCSI, Dublin, Ireland.
⁹ Department of International Health and Tropical Medicine, RCSI, Dublin, Ireland.
¹⁰ Irish Centre for Vascular Research, School of Pharmacy & Biomedical Sciences, RCSI, Dublin, Ireland.

No abstract available

Keywords: COVID-19; blood group; coagulopathy; haemorrhage; transfusion.

Conflict of interest statement

The authors have no conflicts of interest relevant to this publication to declare.

1. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18:844‐847. - PMC - PubMed
1. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID‐19. J Thromb Haemost. 2020;18(5):1023‐1026. - PMC - PubMed
1. Fogarty H, Townsend L, Ni Cheallaigh C, et al. COVID19 coagulopathy in Caucasian patients. Br J Haematol. 2020;189(6):1044‐1049. - PMC - PubMed
1. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS‐CoV‐2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089‐1098. - PMC - PubMed
1. Middeldorp S, Coppens M, van Haaps TF, et al. Incidence of venous thromboembolism in hospitalized patients with COVID‐19. J Thromb Haemost. 2020;18(8):1995‐2002. - PMC - PubMed